Tim Greten

National Institutes of Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Luca Maccioni

National Institute on Alcohol Abuse and Alcoholism

UNITED STATES

View details

Firouzeh Korangy

National Institutes of Health

UNITED STATES

View details

Mark Yarchoan

Johns Hopkins University

UNITED STATES

View details

Marc Ernstoff

Chief

National Institutes of Health

UNITED STATES

View details

Benjamin Ruf

Head of Research Group

University of Tübingen

GERMANY

View details

Lichun Ma

National Cancer Institute

UNITED STATES

View details

Robert Ferris

UPMC Endowed Professor

University of Pittsburgh School of Medicine

UNITED STATES

View details

Josep M Llovet

Full Professor of Medicine-Hepatic Oncology

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tim Greten

Research Interests

Explore related searches

Contact this professor

Articles (17)

Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer

Disparities in Cholangiocarcinoma Research and Trials: Challenges and Opportunities in the United States

Alcohol-associated liver cancer

Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years

Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape

Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy

Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma

Biomarkers for immunotherapy of hepatocellular carcinoma

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

‘Invisible’ immune checkpoint molecule causing resistance to anti-PD1 therapy in HCC

Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States

Immunology and immunotherapy of cholangiocarcinoma

Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity

Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m6A-mediated epitranscriptomic regulation

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

Interventional radiology meets immuno-oncology for hepatocellular carcinoma

NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice

Collaborators (8)

Luca Maccioni

Firouzeh Korangy

Mark Yarchoan

Marc Ernstoff

Benjamin Ruf

Lichun Ma

Robert Ferris

Josep M Llovet

Make your next move.